bpc 157 for mcl Multifunctionality and Possible Medical Application of the Peptide—Literature and Patent Review BPC-157 and other peptides are

Sikiric, P., Seiwerth, S., Grabarevi, ., Petek, M., Ruman, R., Turkovi, B., Rotkvi, I., Jagi, V., Duvnjak, M., Mie, S., Djai, S., eparovi, J., Veljaa, M., Sallmani, A., Banic, M., & Brki, T

The blockbuster weight loss medications that have transformed conversations about obesity and metabolic healthsemaglutide (Ozempic and Wegovy), tirzepatide (Zepbound or Mounjaro), and retatrutide (a newcomer on the block thats not yet FDA approved but highly anticipated for approval next year)are all peptide-based drugs

All-in-all, not a bad combination of potentials, more so for an active person in Naples recovering from a stubborn ankle sprain

No formal combination study exists in humans

For researchers interested in metabolic health beyond weight loss, both compounds offer benefits

Using 3.0 mL (1.67 mg/mL) is also acceptable but requires larger syringes at higher doses